220 Participants Needed

Hospital Violence Intervention Program for Physical Violence

AH
Overseen ByAshley Hink, MD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Medical University of South Carolina
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Turning the Tide Violence Intervention Program for reducing physical violence?

Research on hospital-based violence intervention programs shows they can reduce repeat violent injuries. For example, one study found that a similar program, Prescription for Hope, was linked to fewer violent reinjuries and new violent crime convictions within two years.12345

Is the Hospital Violence Intervention Program safe for participants?

The research on hospital-based violence intervention programs, including nonviolent crisis intervention training, suggests they are generally safe and focus on reducing violence and improving safety in hospital settings. These programs aim to create a safer environment for both patients and staff by decreasing violent incidents and the need for restraints.16789

How is the Turning the Tide Violence Intervention Program different from other treatments for physical violence?

The Turning the Tide Violence Intervention Program is unique because it uses a comprehensive approach that includes watching a trauma resuscitation video, meeting with a gunshot wound survivor, and undergoing psychiatric assessment, which is not typically part of standard violence intervention programs.1791011

What is the purpose of this trial?

The study's goal is to perform an evaluation of a Southeastern hospital violence intervention program (HVIP) that includes comprehensive patient outcomes, perceived benefits and opportunities for improvement of an HVIP from the perspectives of multiple stakeholders including patients, family members and healthcare providers.

Research Team

AH

Ashley Hink, MD

Principal Investigator

Medical University of South Carolina

Eligibility Criteria

This trial is for individuals aged 16-35 treated at MUSC Charleston who have been injured due to interpersonal or community violence and are fully conscious with a Glasgow coma score of 15 at the time they join the study.

Inclusion Criteria

I am between 16-35 years old and was treated for an injury from violence at MUSC Charleston.
I am fully alert and oriented.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Enrollment and Baseline Assessment

Participants are enrolled and baseline assessments are conducted, including surveys on healthcare experience, mental health, and social determinants of health.

1 week
1 visit (in-person)

Intervention and Monitoring

Participants receive services from the hospital violence intervention program (TTVIP) and are monitored for outcomes such as mental health, self-esteem, and risk of violence.

12 months
Assessments at baseline, 3 months, 6 months, and 12 months

Follow-up

Participants are monitored for safety and effectiveness after the intervention, with assessments on outcomes like repeat injury and social determinants of health.

3 months
2 visits (in-person)

Treatment Details

Interventions

  • Turning the Tide Violence Intervention Program
Trial Overview The study evaluates the Turning the Tide Violence Intervention Program at a Southeastern hospital, assessing patient outcomes and gathering insights on benefits and areas for improvement from patients, their families, and healthcare providers.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Patients, family members and healthcare providersExperimental Treatment1 Intervention
Patients that experience violent injuries or are high risk of violence between ages of 15-35 and treated at MUSC Charleston will be enrolled. The hospital violence intervention program is incorporated into regular care of patients, and they may opt to receive services from the program (TTVIP) if they qualify and opt to participate. There is no randomization or assignment. Investigators will assess outcomes of these patients and outcomes will be assessed for between group differences between those that receive services from the program and those that do not. Patient family members and healthcare providers that care for patients will be included and are exposed to the regular healthcare and services provided to patients.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical University of South Carolina

Lead Sponsor

Trials
994
Recruited
7,408,000+

Findings from Research

Over a 10-year period, a hospital-based violence intervention program (VIP) reduced violent reinjury rates to 4%, compared to a historical control rate of 8%, indicating sustained effectiveness in preventing recidivism among participants.
The study identified that addressing specific client needs, particularly in housing and education, significantly impacts reinjury rates, highlighting the importance of tailored support for underserved populations, especially among Latino and white clients.
A decade of hospital-based violence intervention: Benefits and shortcomings.Juillard, C., Cooperman, L., Allen, I., et al.[2018]
The Prescription for Hope (RxH) program significantly reduced the odds of violent reinjury among participants, with a 65% lower chance of being reinjured after a violent incident, based on a study of 992 patients over a 2-year period.
However, participation in RxH was also associated with increased odds of new convictions for violent crime, suggesting that while the program may help prevent further injuries, it may not address underlying issues related to violent behavior.
Violent injury prevention does not equal to violent crime prevention: an analysis of violence intervention program efficacy using propensity score methods.Holler Mph, E., Ortiz Md, D., Mohanty Md Ms, S., et al.[2022]
Out of 2,243 violently injured patients, 839 (37.4%) engaged with the Boston Violence Intervention Advocacy Program (VIAP), with younger age, Black race, and more severe injuries being significant predictors of engagement.
Clients who engaged with VIAP faced challenges in achieving goals related to education, employment, and housing, indicating that while the program is effective in reaching its target population, there is a need for tailored strategies to address these complex needs.
Boston Violence Intervention Advocacy Program: Challenges and Opportunities for Client Engagement and Goal Achievement.Pino, EC., Fontin, F., James, TL., et al.[2021]

References

A decade of hospital-based violence intervention: Benefits and shortcomings. [2018]
Violent injury prevention does not equal to violent crime prevention: an analysis of violence intervention program efficacy using propensity score methods. [2022]
Boston Violence Intervention Advocacy Program: Challenges and Opportunities for Client Engagement and Goal Achievement. [2021]
Reducing violence against nurses: the violence prevention community meeting. [2019]
Hospital-based violence intervention: risk reduction resources that are essential for success. [2022]
Nonviolent crisis intervention training and the incidence of violent events in a large hospital emergency department: an observational quality improvement study. [2014]
Hospital-based violence intervention programs work. [2022]
Reducing restraints: alternatives to restraints on an inpatient psychiatric service--utilizing safe and effective methods to evaluate and treat the violent patient. [2019]
Cost-benefit analysis simulation of a hospital-based violence intervention program. [2017]
10.United Statespubmed.ncbi.nlm.nih.gov
A prospective randomized study of the efficacy of "Turning Point," an inpatient violence intervention program. [2018]
Assessing improvements in emergency department referrals to a hospital-based violence intervention program. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security